Prestige Brand Holdings has initiated a voluntary recall of nearly 40,000 bottles of its Clear Eyes Maximum Itchy Eye Relief eye drops due to concerns regarding the sterility of the product. The U.S. Food and Drug Administration (FDA) has flagged this issue, leading to the removal of these eye drops from store shelves nationwide.
The FDA has classified this recall as Class II, indicating a moderate risk. This means that while exposure to the product might cause temporary or medically reversible adverse health effects, the likelihood of serious health consequences is considered remote. The company is taking this action to ensure product safety and address the potential for contamination.
Prestige Brands Recalls 40,000 Bottles of Clear Eyes Eye Drops for Sterility Concerns
16 stories · 9 sources
#melatonin #cognition #researchOther digests
- 2026-09-13 — Scientists Uncover Molecular Switch to Halt Inflammation
- 2026-09-12 — New Research Explores Resistance Training for Muscle Function and Hypertrophy
- 2026-09-11 — Bouncy Castle MRSA Outbreak Infects 48 Children in Ireland
- 2026-09-10 — Esther Rantzen Too Frail for Swiss Assisted Dying
- 2026-09-09 — Apple's Health App to Feature 'Health Age' and Readiness Scores
- 2026-09-08 — Toilet Flushes Disperse Pathogen Plumes, Study Warns
- 2026-09-07 — BBC Anchor Maryam Moshiri Discloses Incurable Blood Cancer Diagnosis
- 2026-09-06 — Alzheimer's Prevention Trial Begins; Pig Kidney Transplant Patient Progresses
- 2026-09-05 — Alzheimer's Prevention Trial Targets Asymptomatic Individuals
- 2026-09-04 — Novartis Heart Drug Pelacarsen Trial Fails, Disappointing Medical Community
- 2026-09-03 — Genetically Modified Pig Kidney Sustains Man for Nine Months
- 2026-09-02 — Researchers Explore Brain 'Knobs' for Cognitive Enhancement
- 2026-09-01 — CDC Reports, Then Deletes, Measles Deaths Amidst Scrutiny
- 2026-08-31 — North Carolina Teen Dies From Rare Brain-Eating Amoeba Infection
- 2026-08-30 — Statins Show Promise for Heart Attack and Stroke Prevention in Healthy Over-70s
- 2026-08-29 — Psilocybin May Enhance Present Moment Brain Activity, Study Suggests
- 2026-08-28 — Global Heart Attack Definition Updated for Improved Patient Care
- 2026-08-27 — Antidepressant Withdrawal Management Improving Among Doctors
- 2026-08-26 — FDA Approves Daraxonrasib, Groundbreaking Targeted Therapy for Pancreatic Cancer
- 2026-08-25 — FDA Approves First Wearable Device for Combined Ketone and Blood Sugar Monitoring
- 2026-08-24 — Experts Recommend Meat Probes Amidst Widespread Salmonella Concerns
- 2026-08-23 — Vitamin D Linked to Improved Cognition in Sleep-Disturbed, Mildly Impaired Individuals
- 2026-08-22 — Prestige Brands Recalls 40,000 Bottles of Clear Eyes Eye Drops for Sterility Concerns
- 2026-08-21 — Study Examines Cancer Mortality in US Pilots and Flight Attendants
- 2026-08-20 — ADHD Documentary Criticized for Bias, Expert Withdraws Support
- 2026-08-19 — ADHD Documentary Sparks Outrage, Charity Lodges Complaint
- 2026-08-18 — Poor Sleep May Shorten Careers by Nine Months After Age 50
- 2026-08-17 — US Vaccination Rates Decline Amidst Rising Exemptions, CDC Data Reveals
- 2026-08-16 — New Alzheimer's Surgery Shows Promise; Weight-Loss Drugs Linked to Dementia Risk Reduction
- 2026-08-15 — Health Science Research Digest